What contributes to healthy living behaviors among children? It depends...

December 08, 2015

OTTAWA, Canada - December 8, 2015 - Scientists from the Children's Hospital of Eastern Ontario (CHEO) Research Institute participated in several peer-reviewed articles that published today in the International Journal of Obesity Supplements. The series (including 16 original contributions) was prepared by the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE) research group, a global collective of leading obesity research experts from 12 countries located on five continents.

"These are the first standardized, directly-measured data ever presented across countries from low- to high-income, and they bust some strongly held beliefs about key correlates of childhood obesity and healthy living behaviours," said Dr. Mark Tremblay, Director of the Healthy Active Living and Obesity (HALO) research group at the CHEO Research Institute and co-Principal Investigator of ISCOLE Canada. "Bottom line, contributors to childhood obesity can be quite different between countries. These novel findings suggest that a 'one size fits all' approach to obesity prevention is misguided and international insights may lead to innovative, out of the box solutions."

Dr. Jean-Philippe Chaput, HALO scientist at the CHEO Research Institute and co-Principal Investigator of ISCOLE Canada led a first of its kind study to look at the link between sleep patterns and lifestyle behaviours in children from 12 countries in five major geographic regions of the world. The findings reveal that short sleep duration, poor sleep quality and later bedtimes are all associated with unhealthy lifestyle habits. However, the relationships were stronger in high-income countries compared to low/middle income countries; suggesting that interventions aimed at improving sleep and lifestyle behaviours should be culturally adapted to maximize success.

"It is possible that children's days are too structured or regulated in high-income countries and that there is more flexibility and discretionary time in low-income countries," said Dr. Chaput. "Sleep should not be overlooked by parents or health care practitioners and must be part of the lifestyle package that traditionally has focused on diet and exercise."

Dr. Richard Larouche, Post-doctoral fellow at the CHEO Research Institute led a study examining what distinguishes children who engage in active school transport (that is the use of non-motorized modes such as walking and cycling to get to and from school) from those who do not. Across countries, children who engage in active transportation are less likely to be overweight or obese and they are also more physically active.

"Overall, 42.1% of children reported engaging in active transportation, but across countries, this varied from 5.2% in India to 79.4% in Finland. In the Canadian site (Ottawa), 35.1% of children engaged in active transportation," said Dr. Larouche. The factors associated with active school transport varied widely across countries. According to Dr. Larouche, "These findings challenge the belief that there is a common (or universal) set of factors associated with active transportation."
-end-
About ISCOLE

The International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE) represents a global collaboration among childhood obesity researchers from low, middle and high income countries. Countries in ISCOLE include Australia, Brazil, Canada, China, Colombia, Finland, India, Kenya, Portugal, South Africa, United Kingdom and the United States. Most research published to date on the contributors of childhood obesity has been conducted in Western, high-income countries, whereas ISCOLE places a strong emphasis on understanding the range of contributors across countries that differ widely in levels of human development. For more information on ISCOLE, see http://www.biomedcentral.com/content/pdf/1471-2458-13-900.pdf

About the CHEO Research Institute

The CHEO Research Institute coordinates the research activities of the Children's Hospital of Eastern Ontario (CHEO) and is affiliated with the University of Ottawa. Its three programs of research include molecular biomedicine, health information technology, and evidence to practice research. Key themes include cancer, diabetes, obesity, mental health, emergency medicine, musculoskeletal health, electronic health information and privacy, and genetics of rare disease. The CHEO Research Institute makes discoveries today for healthier kids tomorrow. For more information, visit http://www.cheori.org

Children's Hospital of Eastern Ontario Research Institute

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.